small molecule activators sirt1 therapeutics treatment type diabetes 
calorie restriction extends lifespan produces metabolic profile desirable treating diseases ageing type diabetes12 sirt1 nad+-dependent deacetylase principal modulator pathways downstream calorie restriction produce beneficial effects glucose homeostasis insulin sensitivity3- resveratrol polyphenolic sirt1 activator mimics anti-ageing effects calorie restriction lower organisms mice fed high-fat diet ameliorates insulin resistance increases mitochondrial content prolongs survival10- describe identification characterization small molecule activators sirt1 structurally unrelated -fold potent resveratrol compounds bind sirt1 enzyme-peptide substrate complex allosteric site amino-terminal catalytic domain lower michaelis constant acetylated substrates diet-induced obese genetically obese mice compounds improve insulin sensitivity lower plasma glucose increase mitochondrial capacity zucker fa/fa rats hyperinsulinaemic-euglycaemic clamp studies demonstrate sirt1 activators improve whole-body glucose homeostasis insulin sensitivity adipose tissue skeletal muscle liver thus sirt1 activation promising new therapeutic approach treating diseases ageing type diabetes 
